(S)-2-(Cyclobutylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)isonicotinamide Attenuates RANKL-Induced Osteoclast Differentiation by Inhibiting NF-κB Nuclear Translocation
Mina Ding(Tianjin University of Science and Technology), Tae‐Hoon Lee(Children's Hospital of Philadelphia)
Cited by 16
Related Papers
RtxA1‐Induced Expression of the Small GTPase Rac2 Plays a Key Role in the Pathogenicity of<i>Vibrio vulnificus</i>
|The Journal of Infectious Diseases|2009|57
Proteomic Analysis of Gingival Tissue and Alveolar Bone during Alveolar Bone Healing
|Molecular & Cellular Proteomics|2013|25
Inhibitory Effects of N-[2-(4-acetyl-1-piperazinyl) phenyl]-2-(2-chlorophenoxy) acetamide on Osteoclast Differentiation In Vitro via the Downregulation of TRAF6
|International Journal of Molecular Sciences|2019|24
PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption
|Molecules|2019|16